News
Leeds researchers have identified new targets for drugs to treat lupus
Dr Elton Zeqiraj, Dr Francesco Del Galdo and colleagues have discovered a new regulator of the immune response which could be a new target for drugs to tackle autoimmune diseases.
Less chemotherapy better for older or frail patients with advanced stomach and esophageal cancers
Research by Leeds academics suggests less chemotherapy is as effective at controlling the disease in frail patients with cancer of the stomach or oesophagus , and leads to fewer symptoms.
New research indicates smoking may limit body’s ability to fight melanoma
Melanoma patients with a history of smoking cigarettes are 40 per cent less likely to survive their skin cancer than people who have never smoked, according to new research.
Leeds academics find inadequate support for sexual dysfunction in prostate cancer patients
More than 4 in 5 men (81%) with prostate cancer struggle with poor sexual function following treatment for the disease, but over half (56%) fail to receive support, according to new research.
Research grant will aid in understanding microbiomes' roles in bowel cancers
Professor Philip Quirke, from the Leeds Institute for Medical Research at St James’s, has been awarded nearly £2.5 million from Cancer Research UK, as part of their new Grand Challenge funding.